E qetetse ho nchafatsoa ka la 8 Loetse 2022 ka 09:16 hoseng
Lethathamo la Top Swiss Based Likhamphani tsa meriana tse hlophisoang ho ipapisitsoe le kakaretso ea Lekeno la selemo sa morao tjena. Roche ke eona e kholo ka ho fetisisa Khamphani ea Meriana Switzerland ka Lekeno la $ 66 Bilione selemong se fetileng e lateloe ke Novartis le Vifor.
Roche - E kholo ka ho fetisisa Khamphani ea Pharma Switzerland: Ho theosa le nalane ea lilemo tse 125, Roche e se e holile ho ba e 'ngoe ea lik'hamphani tse kholo ka ho fetisisa lefatšeng tsa biotech, hape e le mofani ea ka sehloohong oa tlhahlobo ea invitro le mofani oa lefats'e oa litharollo tse ntlafatsang libakeng tse kholo tsa mafu.
Lethathamo la Likhamphani tse holimo tsa Switzerland tsa Pharmaceutical
Kahoo mona ke Lethathamo la Lits'oants'o tse Hloahloa tsa Switzerland meriana Likhamphani ka kakaretso ea Thekiso (Lekeno).
S. NO | Tlhaloso | Chelete eohle | basebetsi ba | Sekoloto-to-Tekano Ratio | Khutlela ho Equity | Letšoao la Setoko |
1 | Roche | $ Limilione tse 65,980 | 101465 | 0.4 | 40.4 | RO |
2 | NOVARTIS | $ Limilione tse 51,668 | 105794 | 0.6 | 17.3 | NOVN |
3 | VIFOR | $ Limilione tse 1,930 | 2600 | 0.2 | 5.9 | VIFN |
4 | TS'ELISITSOE | $ Limilione tse 956 | 2500 | 0.9 | 13.9 | SFZN |
5 | BACHEM | $ Limilione tse 455 | 1529 | 0.3 | 21.3 | BANB |
6 | BASILEA | $ Limilione tse 144 | 150 | -2.9 | BSLN | |
7 | IDORSIA | $ Limilione tse 81 | 5.5 | -237.9 | KHOPOTSO | |
8 | COSMO PHARM | $ Limilione tse 74 | 265 | 0.5 | -2.8 | KOPN |
9 | SANTHERA | $ Limilione tse 17 | 91 | 5.2 | -1316.2 | SAN |
10 | SPEXIS N | $ Limilione tse 16 | 52 | -1.6 | -347.9 | SPEX |
11 | EVOLVA N | $ Limilione tse 9 | 65 | 0.1 | -29.1 | EVE |
12 | NEWRON PHARMA N | $ Limilione tse 6 | 3.1 | -110.5 | NWRN | |
13 | ADDEX N | $ Limilione tse 4 | 27 | 0.0 | -89.8 | ADXN |
Novartis - Khampani ea bobeli e kholo ea Switzerland ea Pharma
Novartis e thehiloe ka 1996 ka kopanyo ea Ciba-Geigy le Sandoz. Novartis le lik'hamphani tsa pele ho eona li qalile morao lilemong tse fetang 250, ka nalane e ruileng ea ho hlahisa lihlahisoa tse ncha.
Novartis e ntse e nahana ka meriana ho ntlafatsa le ho lelefatsa bophelo ba batho. Joalo ka k'hamphani e etelletseng pele ea meriana lefatšeng ka bophara, k'hamphani e sebelisa mahlale a macha le mahlale a dijithale ho theha liphekolo tse fetohang libakeng tse nang le tlhoko e kholo ea bongaka. Morerong oa rona oa ho fumana meriana e mecha, khamphani e lula e le maemong a lefats'e lik'hamphani tse holimo ho tsetela lipatlisisong le ntlafatsong.
Lihlahisoa tsa Novartis li fihla ho batho ba ka bang limilione tse 800 lefatšeng ka bophara 'me re ntse re fumana mekhoa e mecha ea ho holisa phihlello ea liphekolo tsa rona tsa morao-rao. Batho ba ka bang 110,000 ba lichaba tse fetang 140 ba sebetsa Novartis lefatšeng ka bophara.
Vifor Pharma
Vifor Pharma Group ke k'hamphani ea lefats'e ea meriana. E ikemiselitse ho ba moetapele oa lefats'e oa khaello ea tšepe le nephrology ka ho tsepamisa maikutlo ho mafu a sa tloaelehang. Khampani ke molekane oa khetho bakeng sa meriana le litharollo tse ncha tse shebaneng le bakuli.
Vifor Pharma Group e ikitlaelletsa ho thusa bakuli lefatšeng ka bophara ba nang le mafu a matla le a sa foleng ho phela bophelo bo betere, bo phetseng hantle.
Bachem
Bachem e thehiloe ka 1971 ke Peter Grogg e le Bachem Feinchemikalien AG e nang le basebetsi ba babeli Liestal haufi le Basel e shebane le peptide synthesis. Ka 1977, Bachem o ile a fallela Bubendorf le basebetsi ba robeli 'me ka 1978 a hlahisa li-peptide bakeng sa tšebeliso ea meriana tlas'a tataiso ea GMP ka lekhetlo la pele. Pakeng tsa 1981 le 1991, Bachem e ile ea eketsa matla a eona a tlhahiso ka makhetlo a mararo, ha palo ea basebetsi e ile ea eketseha ho ea ho 150. Ka 1995, mehaho, ho kenyeletsa le lefapha la taolo ea boleng, e ile ea atolosoa ho ea ho 168,000 sq. ft. (15,600 m2). Palo ea basebetsi e ile ea nyolohela ho 190.
Katoloso ea limmaraka tseo e seng tsa Europe e qalile ha ho thehoa Bachem Bioscience, Inc. e Philadelphia, USA, ka 1987. Ho matlafatsa boteng ba eona Europe, Bachem e ile ea bula litsi tsa thekiso le tsa ho bapatsa Jeremane ka 1988 le France ka 1993. Ka 1996, e ile ea fumana moetsi oa bobeli o moholo oa li-peptide, Bachem California e Torrance, USA, hammoho le lithuso tsa eona tsa Jeremane le UK.
Bachem e qala ho phatlalatsa ka June 18, 1998. Likarolo li thathamisitsoe ho Swiss Stock Exchange. Sehlopha se fihletse thekiso ea li-CHF tse limilione tse 96 mme sa hira batho ba 331 lefatšeng ka bophara. Ka 1999, Bachem e fumana Peninsula Laboratories, Inc., e thehiloeng San Carlos, California, le setsi sa eona sa Engelane, se kopantsoeng le Bachem UK - ka boeona qalong e ne e le setsi sa California-based Bachem Inc. ka 2000.
Ho nkuoa ha Sochinaz SA, moetsi ea ikhethileng oa Switzerland (Vionnaz) oa metsoako e sebetsang ea meriana ka 2001, e matlafalitse boitsebelo ba Bachem mme hape ea eketsa bokhoni ba eona ba tlhahiso. The headcount of the Group e ile ea hōla ka nako ena ho basebetsi ba 500 le thekiso e fihlile ho 141,4 milione CHF.
Kahoo qetellong ana ke Lethathamo la Likhamphani tse holimo tsa Switzerland tse thehiloeng ho Pharmaceutical tse ipapisitseng le thekiso ea selemo sa morao tjena.
Bala Haholoanyane ka Likhamphani tse holimo tsa Pharma India.